Literature DB >> 5779160

G-6PD Bangkok: a new variant found in congenital nonspherocytic hemolytic disease (CNHD).

P Talalak, E Beutler.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1969        PMID: 5779160

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  8 in total

1.  Glucose-6-phosphate dehydrogenase Boston. A new variant associated with congenital nonspherocytic hemolytic disease.

Authors:  T F Necheles; I M Snyder; W Strauss
Journal:  Humangenetik       Date:  1971

2.  [Glucose-6-P-dehydrogenase type bodensee (a new enzyme variant)].

Authors:  H C Benöhr; H D Waller; H Arnold; K G Blume; G W Löhr
Journal:  Klin Wochenschr       Date:  1971-10-01

3.  Glucose 6-phosphate dehydrogenase variants of Bali island (Indonesia).

Authors:  K Chockkalingam; P G Board; G Breguet
Journal:  Hum Genet       Date:  1982       Impact factor: 4.132

4.  Somatic-cell selection is a major determinant of the blood-cell phenotype in heterozygotes for glucose-6-phosphate dehydrogenase mutations causing severe enzyme deficiency.

Authors:  S Filosa; N Giacometti; C Wangwei; D De Mattia; D Pagnini; F Alfinito; F Schettini; L Luzzatto; G Martini
Journal:  Am J Hum Genet       Date:  1996-10       Impact factor: 11.025

5.  Three new electrophoretically normal glucose-6-phosphate dehydrogenase variants associated with congenital nonspherocytic hemolytic anemia found in Japan: G6PD Ogikubo, Yokohama, and Akita.

Authors:  S Miwa; H Fujii; K Nakashima; Y Miura; K Yamada; T Hagiwara; M Fukuda
Journal:  Hum Genet       Date:  1978-11-24       Impact factor: 4.132

6.  Glucose-6-phosphate dehydrogenase in Thailand. The occurrence of three electrophoretic variants among 1157 nondeficient males.

Authors:  V Panich
Journal:  Hum Genet       Date:  1980-02       Impact factor: 4.132

7.  Systematic review of the clinical manifestations of glucose-6-phosphate dehydrogenase deficiency in the Greater Mekong Subregion: implications for malaria elimination and beyond.

Authors:  Ken Ing Cherng Ong; Hodaka Kosugi; Sophea Thoeun; Hitomi Araki; Moe Moe Thandar; Moritoshi Iwagami; Bouasy Hongvanthong; Paul T Brey; Shigeyuki Kano; Masamine Jimba
Journal:  BMJ Glob Health       Date:  2017-08-19

8.  A trade off between catalytic activity and protein stability determines the clinical manifestations of glucose-6-phosphate dehydrogenase (G6PD) deficiency.

Authors:  Usa Boonyuen; Kamonwan Chamchoy; Thitiluck Swangsri; Thanyaphorn Junkree; Nicholas P J Day; Nicholas J White; Mallika Imwong
Journal:  Int J Biol Macromol       Date:  2017-06-03       Impact factor: 6.953

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.